No insider purchase over the last 90 days. The latest was filed 09 Mar 2022.
This page follows insider dealings at Weave Communications, Inc. as filed with SEC (Form 4), a company from the Business Services sector. Over the twelve months to 18 October 2026, the company's managers filed 34 filings, from 10 insiders.
The flow runs one way only: 3 sales worth €472k, from 3 insiders, and no purchase. The largest single trade was a sale of €297k by Newton Tyler, published on 7 November 2025.
Across the 5,808 companies tracked on its exchange, the median is 19 filings; at 34 filings, this issuer sits above that mark. Over the whole record (from 2021), the tally stands at 5 purchases and 99 sales. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 239.0 m USD and net income of -28.1 m USD.
Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
Other companies in the same sector with recent insider buying flagged by our signals: Coursera, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
+4 other insiders
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 290 declarations
Weave Communications, Inc. (ticker: WEAV) is a U.S.-based software company listed on the NYSE in the United States, focused on vertical SaaS solutions for small and medium-sized healthcare practices. Founded in 2008 and headquartered in Lehi, Utah, Weave has built an all-in-one platform designed to manage the patient journey end to end, from the first phone call to the final invoice. The company’s business model is anchored primarily in recurring subscription revenue, supplemented by payment-processing services and some hardware-related fees, which gives it a more durable and visible revenue profile than a purely transactional software business. In its annual report, Weave stated that most of its customers are in the U.S. and Canada, with a concentration in dental, optometry, veterinary, and other specialty medical practices. As of the end of 2024, the company reported roughly 35,000 locations under subscription and more than 30,000 customers, indicating meaningful scale within its niche. Weave positions itself as an integrated customer experience and payments platform that combines telephony, messaging, scheduling, digital forms, reviews, internal collaboration, insurance verification, and payments such as text-to-pay and online bill pay. This integrated workflow is a core competitive advantage versus fragmented point solutions and generic horizontal software vendors. The company also emphasizes authorized integrations with practice management systems and an AI-enabled layer embedded across the platform to automate and personalize patient communications. Strategically, Weave is aiming to deepen adoption within its installed base, expand into multi-location practices, and broaden into adjacent specialty healthcare verticals. Recent milestones include the announced acquisition of TrueLark, an AI receptionist and front-desk automation platform, which should strengthen Weave’s agentic AI capabilities and front-office automation roadmap. In 2025 and 2026, the company also highlighted product enhancements, patient-financing partnerships, and recognition from the American Dental Association as an endorsed patient engagement solution. For investors, Weave offers a compelling exposure to healthcare software digitization, AI-enabled workflow automation, and payments embedded within patient communications, all within a niche vertical SaaS model that remains relatively focused but potentially scalable.
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 12 filings published between 17 July and 8 October 2026: no open-market purchase or sale filed by an insider. 12 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 14 October 2026 (UTC)
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2025 | 239.0 m USD | -28.1 m USD | -0.37 USD | 10-K |
| Dec 2024 | 204.3 m USD | -28.3 m USD | -0.40 USD | 10-K |
| Dec 2023 | 170.5 m USD | -31.0 m USD | -0.46 USD | 10-K |
| Dec 2022 | 142.1 m USD | -49.7 m USD | -0.76 USD | 10-K |
| Dec 2021 | 115.9 m USD | -51.7 m USD | -2.60 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.